ROSEN Law Firm Urges Aquestive Therapeutics Investors to Seek Legal Counsel

The firm is encouraging investors to explore potential claims against the company.

Mar. 30, 2026 at 1:17am

Got story updates? Submit your updates here. ›

The ROSEN Law Firm, a global investor rights law practice, is urging investors in Aquestive Therapeutics, Inc. to seek legal representation to explore potential claims against the company. The announcement comes as the firm believes investors may have claims due to issues related to the company's business and financial performance.

Why it matters

Aquestive Therapeutics is a pharmaceutical company that develops and commercializes complex drug delivery solutions. The ROSEN Law Firm's announcement suggests there may be concerns about the company's operations and transparency with investors, which could impact shareholder value.

The details

The ROSEN Law Firm did not provide specific details about the potential claims against Aquestive Therapeutics. However, the firm stated it is investigating the company's business practices and financial reporting to determine if investors have grounds to pursue legal action.

  • The announcement was made on March 29, 2026.

The players

ROSEN Law Firm

A global investor rights law practice that specializes in representing investors in securities fraud class actions and shareholder derivative litigation.

Aquestive Therapeutics, Inc.

A pharmaceutical company that develops and commercializes complex drug delivery solutions.

Got photos? Submit your photos here. ›

What’s next

The ROSEN Law Firm is urging investors to contact the firm to discuss potential legal action against Aquestive Therapeutics.

The takeaway

This announcement suggests there may be concerns about Aquestive Therapeutics' business practices and financial reporting, which could impact shareholder value. Investors are encouraged to seek legal counsel to understand their options.